AADAT and Parkinson disease: The red blood cells (RBCs) and plasma of PD patients were evaluated for KYNA and the biosynthetic enzymes (KAT1 and KAT2), where enhanced KYNA levels along with KAT2 were observed, which may be a sequential pathway against the excitatory neurotoxic effects [109].